Improved Passivation Method for Metallic Orthopaedic Implants
Smith & Nephew Richards
FDA Clearance Information
The device was cleared through the FDA 510(k) pathway on June 14, 1995, by Smith & Nephew Richards. It is classified as a Class 2 medical device under product code HWC.
What It Is
FDA-Cleared Indications
- Use as a passivation treatment for metallic orthopedic implant components.
- Treatment intended to improve the corrosion resistance and surface properties of metallic orthopedic implants.
- Use with metallic orthopedic implants in orthopedic surgical applications covered by the device labeling.
Clinical Applications
- Passivation of metallic components used in joint replacement implants.
- Passivation of metallic components used in fracture-fixation implants.
- Surface treatment of metallic orthopedic implants before clinical use.
- Use when improved corrosion resistance and biocompatibility of a metallic implant surface are desired.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- This is a manufacturing or surface-treatment method rather than an independently implanted device; the implant's own labeling determines its permitted clinical use.
- Compatibility depends on the implant metal, alloy, coating, geometry, and processing specifications.
- Handling and sterilization must follow the implant manufacturer's instructions because additional processing can affect the treated surface.
- MRI safety is determined by the finished implant and its components, not by passivation alone; review the implant's MRI labeling.
- Contraindications, warnings, sizes, and expected service life are specific to the finished orthopedic implant.
Frequently Asked Questions
What are the clinical indications for improved passivation method for metallic orthopaedic implants?
The device is indicated for use in orthopaedic surgeries requiring metallic implants, particularly where enhanced stability and reduced corrosion are desired.
What outcomes have been reported in clinical studies?
Studies suggest improved implant stability and reduced oxidation, but specific clinical outcomes are not detailed in the provided evidence.
What complications have been reported?
Reported complications include potential issues with the passivation process, though specific adverse events are not detailed in the evidence.